Acitretin Capsules, USP are indicated for the treatment of severe psoriasis in adults.  Because of significant adverse effects associated with its use, Acitretin Capsules, USP should be prescribed only by those knowledgeable in the systemic use of retinoids.

Acitretin Capsules, USP
  • Compare to
    Soriatane®*
*Soriatane® is a registered trademark of Stiefel Laboratories, Inc.

Acitretin Capsules, USP (10 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    10 mg
  • NDC Code
    42794-0080-08
Acitretin Capsules, USP (10 mg)

Acitretin Capsules, USP (17.5 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    17.5 mg
  • NDC Code
    42794-0081-08
Acitretin Capsules, USP (17.5 mg)

Acitretin Capsules, USP (25 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    25 mg
  • NDC Code
    42794-0083-08
Acitretin Capsules, USP (25 mg)

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.